Literature DB >> 11055658

Risk and patterns of bacteraemia after splenectomy: a population-based study.

P Ejstrud1, B Kristensen, J B Hansen, K M Madsen, H C Schønheyder, H T Sørensen.   

Abstract

During a period in which vaccination of splenectomized patients has been recommended, we analysed the patterns of severe post-splenectomy infections (i.e. bacteraemia or meningitis) in a defined population-based cohort. A total of 561 patients undergoing splenectomy were identified during 1984-93 in a Danish county, and the 538 eligible patients were followed for 1731 person-years. After splenectomy, 38 patients contracted a bacteraemia, of which 45% occurred within 30 d (i.e. during the postoperative period). No cases of meningitis were found. Among splenectomized patients the incidence rate of bacteraemia was 2.3 per 100 person-years at risk. Beyond the postoperative period we found an 8-fold increased risk of bacteraemia. Enterobacteria were the predominant cause (45%), and only 1 case due to Streptococcus pneumoniae was recorded. 89 (17%) died during the postoperative period, and the overall mortality rate was 18.4 per 100 person-years at risk. In all, 60% of the patients had been given a pneumococcal vaccination, and a Cox proportional hazard regression model showed that vaccination significantly reduced the risk of bacteraemia of any cause beyond the postoperative period. We conclude that splenectomy increases the risk of severe infections, and that vaccinated patients carry a lower risk of infection than non-vaccinated ones.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11055658     DOI: 10.1080/003655400458811

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  27 in total

1.  CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

Authors:  Aras Kadioglu; William Coward; M Joseph Colston; Colin R A Hewitt; Peter W Andrew
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Vaccination coverage in adults undergoing splenectomy: evaluation of hospital vaccination policies.

Authors:  L Bruni; J M Bayas; A Vilella; A Conesa
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

3.  Outcomes after splenectomy in children: a 48-year population-based study.

Authors:  Mohammad A Khasawneh; Nicolas Contreras-Peraza; Matthew C Hernandez; Christine Lohse; Donald H Jenkins; Martin D Zielinski
Journal:  Pediatr Surg Int       Date:  2019-02-02       Impact factor: 1.827

4.  Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up.

Authors:  Sigurdur Y Kristinsson; Gloria Gridley; Robert N Hoover; David Check; Ola Landgren
Journal:  Haematologica       Date:  2013-09-20       Impact factor: 9.941

Review 5.  Splenectomy for immune thrombocytopenia: down but not out.

Authors:  Shruti Chaturvedi; Donald M Arnold; Keith R McCrae
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

Review 6.  Phagocytosis and oxycytosis: two arms of human innate immunity.

Authors:  Hayk Minasyan
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

7.  [Distal pancreatectomy: radical or spleen-preserving?].

Authors:  A M Chromik; M Janot; D Sülberg; M H Seelig; W Uhl
Journal:  Chirurg       Date:  2008-12       Impact factor: 0.955

Review 8.  Minimally invasive pancreatic surgery: the new frontier?

Authors:  Basil J Ammori; Saleh Baghdadi
Journal:  Curr Gastroenterol Rep       Date:  2006-04

9.  Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients.

Authors:  G K Wong; S Goldacker; C Winterhalter; B Grimbacher; H Chapel; M Lucas; D Alecsandru; D McEwen; I Quinti; H Martini; C Milito; R E Schmidt; D Ernst; T Espanol; A Vidaller; J Carbone; E Fernandez-Cruz; V Lougaris; A Plebani; N Kutukculer; L I Gonzalez-Granado; R Contreras; S Kiani-Alikhan; M A A Ibrahim; J Litzman; A Jones; H B Gaspar; L Hammarstrom; U Baumann; K Warnatz; A P Huissoon
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

10.  Surgical management of splenic echinococcal disease.

Authors:  G Meimarakis; G Grigolia; F Loehe; K-W Jauch; R J Schauer
Journal:  Eur J Med Res       Date:  2009-04-16       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.